Founded in 2015, Lifeforce Capital focuses on investing in software-driven companies operating in the care delivery and computational drug discovery sectors. By leveraging new technologies and care models, Lifeforce Capital's portfolio companies are driving a shift towards more efficient and innovative approaches to healthcare. With a software-first approach to computational drug discovery, these companies are transforming the traditional biotechnology landscape.